ClinVar Miner

Submissions for variant NM_054012.4(ASS1):c.1088G>A (p.Arg363Gln)

gnomAD frequency: 0.00001  dbSNP: rs771937610
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000185788 SCV000238724 likely pathogenic not provided 2021-02-24 criteria provided, single submitter clinical testing Reported in other individuals reported to have citrullinemia who either did not have a second variant identified in the ASS1 gene or for whom detailed clinical information was not provided (Haberle et al., 2010; Zielonka et al., 2019); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30285816, 24508627, 19006241, 12815590, 28111830, 31469252, 20005624)
Invitae RCV000633525 SCV000754765 pathogenic Citrullinemia 2024-01-09 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 363 of the ASS1 protein (p.Arg363Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with citrullinemia type I (PMID: 30285816, 31469252; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 203631). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASS1 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg363 amino acid residue in ASS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 2358466, 12815590, 14680976, 16124451, 25537548, 26117549, 28111830). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Eurofins Ntd Llc (ga) RCV000185788 SCV000854776 pathogenic not provided 2018-08-29 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV002500568 SCV002807301 likely pathogenic Citrullinemia type I 2021-11-16 criteria provided, single submitter clinical testing
Neuberg Centre For Genomic Medicine, NCGM RCV002500568 SCV004101491 likely pathogenic Citrullinemia type I criteria provided, single submitter clinical testing The missense variant p.R363Q in ASS1 (NM_054012.4) has been previously reported in an individual affected with ASS1-related conditins (Gao et al, 2003). The p.R363Q variant has a gnomAD frequency of 0.0003999 % and is novel (not in any individuals) in 1000 Genomes. There is a small physicochemical difference between arginine and glutamine, which is not likely to impact secondary protein structure as these residues share similar properties. The p.R363Q missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 363 of ASS1 is conserved in all mammalian species. The nucleotide c.1088 in ASS1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. The observed variant is also detected in the spouse.
Baylor Genetics RCV002500568 SCV004202583 pathogenic Citrullinemia type I 2023-09-20 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.